Segment Data (Schedule of Segment Reporting Information by Business Segment) (Details) $ in Millions |
3 Months Ended | 6 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 27, 2025
USD ($)
|
Jun. 28, 2024
USD ($)
|
Jun. 27, 2025
USD ($)
segement
|
Jun. 28, 2024
USD ($)
|
|||||||||
Net sales | $ 485.1 | $ 514.3 | $ 905.0 | $ 982.1 | ||||||||
Operating Income (Loss) | 33.0 | 27.4 | 48.0 | 9.7 | ||||||||
Restructuring charges, net | 0.2 | (0.2) | 2.2 | (10.4) | ||||||||
Separation Costs | [1] | (2.2) | (10.3) | (3.6) | (17.0) | |||||||
Interest Expense | (32.6) | (59.4) | (65.4) | (118.5) | ||||||||
Interest income | 5.9 | 6.0 | 11.7 | 12.8 | ||||||||
Other income (expense), net | 7.2 | (3.5) | 1.4 | 0.2 | ||||||||
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | 13.0 | (29.5) | $ (11.0) | (95.8) | ||||||||
Number of Reportable Segments | segement | 2 | |||||||||||
Cost of sales | 253.3 | 319.3 | $ 470.3 | 623.1 | ||||||||
Selling, general and administrative expenses | 150.6 | 127.9 | 298.1 | 264.8 | ||||||||
Research and development expenses | 23.6 | 29.2 | 44.1 | 57.1 | ||||||||
Depreciation and amortization | 44.8 | 67.2 | ||||||||||
Business Combination, Integration Related Costs | 22.6 | [2] | 0.0 | 43.1 | [2] | 0.0 | ||||||
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal | (0.5) | 0.0 | (6.7) | 0.0 | ||||||||
Specialty Brands | ||||||||||||
Net sales | 264.3 | 274.5 | 471.6 | 531.8 | ||||||||
Restructuring and related charges, net | 0.2 | (0.2) | 2.2 | (10.4) | ||||||||
Depreciation and amortization | 12.2 | 21.5 | 24.3 | 43.9 | ||||||||
Specialty Generics | ||||||||||||
Net sales | 220.8 | 239.8 | 433.4 | 450.3 | ||||||||
Depreciation and amortization | 9.8 | 10.5 | 19.6 | 22.7 | ||||||||
Corporate, Non-Segment | ||||||||||||
Cost of sales | [3] | 4.5 | 5.3 | 7.6 | 7.3 | |||||||
Selling, general and administrative expenses | [3] | 59.9 | 42.0 | 121.5 | 100.4 | |||||||
Research and development expenses | [3] | 9.7 | 10.8 | 17.7 | 19.4 | |||||||
Operating Segments | ||||||||||||
Operating Income (Loss) | 131.9 | 95.8 | 241.5 | 153.8 | ||||||||
Restructuring charges, net | 0.2 | (0.2) | 2.2 | (10.4) | ||||||||
Cost of sales | 248.8 | 314.0 | 462.7 | 615.8 | ||||||||
Selling, general and administrative expenses | 90.7 | 85.9 | 176.6 | 164.4 | ||||||||
Research and development expenses | 13.9 | 18.4 | 26.4 | 37.7 | ||||||||
Operating Segments | Specialty Brands | ||||||||||||
Net sales | 264.3 | 274.5 | 471.6 | 531.8 | ||||||||
Operating Income (Loss) | 87.4 | 44.0 | 138.0 | 76.1 | ||||||||
Restructuring charges, net | 0.2 | (0.2) | 2.2 | (10.4) | ||||||||
Cost of sales | 109.4 | 151.9 | 201.8 | 294.4 | ||||||||
Selling, general and administrative expenses | 59.4 | 66.3 | 118.4 | 125.4 | ||||||||
Research and development expenses | 8.3 | 12.1 | 15.6 | 25.5 | ||||||||
Operating Segments | Specialty Generics | ||||||||||||
Net sales | 220.8 | 239.8 | 433.4 | 450.3 | ||||||||
Operating Income (Loss) | 44.5 | 51.8 | 103.5 | 77.7 | ||||||||
Restructuring charges, net | 0.0 | 0.0 | 0.0 | 0.0 | ||||||||
Cost of sales | 139.4 | 162.1 | 260.9 | 321.4 | ||||||||
Selling, general and administrative expenses | 31.3 | 19.6 | 58.2 | 39.0 | ||||||||
Research and development expenses | $ 5.6 | $ 6.3 | $ 10.8 | $ 12.2 | ||||||||
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Total restructuring and related expense No definition available.
|
X | ||||||||||
- Definition Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs. No definition available.
|
X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of interest income earned from interest bearing assets classified as other. No definition available.
|
X | ||||||||||
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|